期刊文献+

影响新疆维吾尔族人群胰岛素抵抗的相关因素分析 被引量:2

Analysis of related factors influencing Xinjiang Uygur insulin resistance
原文传递
导出
摘要 目的分析影响新疆维吾尔族人群胰岛素抵抗的相关因素。方法对第三次全国糖尿病流行病学调查中新疆维吾尔族人群的资料进行分析,采用稳态模式评估法的胰岛素抵抗(IR)指数(HOMA-IR)作为IR的评价指标,利用多元线性回归,了解相关因素对其的影响。结果在多元线性回归分析中,未纳入BMI和腰围的情况下,甘油三酯、总胆固醇与HOMA-IR呈正相关(P=0.016,P=0.038);纳入腰围后,腰围与HOMA-IR呈正相关(P=0.000);同时纳入BMI、腰围,BMI、甘油三酯与HOMA-IR呈正相关(P=0.000,P=0.045)。结论在不考虑人体学指标的情况下,单纯从生化指标甘油三酯和总胆固醇就可以初步了解维吾尔族人群IR的情况;"腰围"可以独立的判断IR程度;但当考虑到BMI的因素时,腹围的预测作用就消失了,而被BMI和甘油三酯所取代;在维吾尔族人群中,BMI可能较腹围具有更好的预测作用。 Objective To analyze related factors influencing Xinjiang Uygur insulin resistance. Methods We employed the third national diabetic epidemiological survey--data of Xinjiang Uygur population for analysis, and took HOMA-IR as index of insulin resistance(IR), by using multiple regression analysis, we studied influence of related factors on HOMA-IR. Results In multiple regression analysis, with exclusion of BMI and waist circumference(WC), triglyceride(TG) and total cholesterol(TC) was positively correlated with HOMA-IR(P=0.016, P=0.038);then with WC in, WC was positively correlated with HOMA-IR(P=0.000);with both BMI and WC in, BMI and Triglyceride was positively correlated with HOMA-IR(P=0.000, P=0.045). Conclusion Without consideration of BMI and WC, TG and TC could be used as a preliminary understanding of Uygur individual’s IR;and WC could predict IR independently;When BMI was included, predictive role of WC was disappeared, and BMI and TG took its place for instead;BMI might be a stronger predictor than WC in Uygur population.
出处 《中华临床医师杂志(电子版)》 2014年第19期45-47,共3页 Chinese Journal of Clinicians(Electronic Edition)
关键词 维吾尔族 胰岛素抵抗 影响因素 HOMA-IR UYGUR NATIONALITY Insulin resistance Influence factors HOMA-IR
  • 相关文献

参考文献10

  • 1Yang W, Lu J, Wong J, ctal. Prevalencv of diabctvs among men and womon in China[J]. N Engl J Med, 2010, 362(12): 1090-1101.
  • 2杨思进,马依彤,刘芬,杨毅宁,李晓梅,黄莺,陈邦党,马翔,谢翔,杜雷,高霞,陈平.新疆维吾尔族、哈萨克族糖尿病的患病率调查及相关危险因素分析[J].中华内分泌代谢杂志,2011,27(5):395-398. 被引量:40
  • 3More E, GaUina P, Pais M, et al. Hypertriglyceridemia is associated with increased insulin resistance in subjects with normal glucose tolerance: evaluation in a large cohort of subjects assessed with the 1999 World Health Organization criteria for the classification of diabetes[J]. Metabolism, 2003, 52(5): 616-619.
  • 4Bonadonna RC, Gronp L, Kraemer N, et al. Obesity and insulin resistance in humans: a dose-response study[J]. Metabolism, 1990, 39(5): 452-459.
  • 5Jabcr LA, Brown MB, Harnmad A, et al. The prevalence of the metabolic syndrome among arab americans[J]. Diabetes Care, 2004, 27(1): 234-238.
  • 6Khoo CM, Sairazi S, Taslim S, et al. Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population[J]. Diabetes Care, 2011, 34(S): 1120-1126.
  • 7Seidell JC. Obesity, insulin resistance and diabetes-a worldwide epidemic[J]. Br J Nutr, 2000, 83 Suppl l: S5-8.
  • 8中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3058
  • 9Grundy SM, Cleeman JI, Danials SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Heart, Lung, and Blood Institute Scientific Statement[J]. Circulation, 2005, 112(17): 2735-2752.
  • 10Zimmet P, Alberti K: Serrano RM. A New International Diabetes Federation (IDF) Worldwide Definition of the Metabolic Syndrome: the Rationale and the Results[J]. Rev Esp Cardiol (Engl Ed), 2005, 58(12): 1371-1375.

二级参考文献13

  • 1王陇德.中国居民营养与健康状况调查报告.北京:人民卫生出版社,2006:48-53.
  • 2International Diabet Federation. Diabet Atlas. 3rd ed. 2007.
  • 3Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med,2010,362 : 1090-1101.
  • 4World Health Organization. Diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1 : Diagnosis and classification of diabetes mellitus. Geneva: WHO, Diagnosis, 1999.
  • 5Yan W, Yang X,Zheng Y, et al. The metabolic syndrome in Uygur and Kazak populations. Diabetes Care ,2005,28:2554.
  • 6Kadowaki T, Hara K, Yamauchi T, et al. Molecular mechanism of insulin resistance and obesity. Biol Med ,2003,228:11.
  • 7樊勇,谢自敬,胡尔西达,木合塔尔,阿地力,木尼热.新疆维吾尔族62个2型糖尿病家系的遗传特性分析[J].中国组织工程研究与临床康复,2007,11(39):7721-7724. 被引量:4
  • 8焦淑芳 王瑜 庞星火 等.北京市居民糖尿病患病现况及影响因素.中华预防医学杂志,2005,39:3-5.
  • 9潘长玉.从循证医学看糖尿病伴高血压患者的血压管理策略[J].中华内分泌代谢杂志,2010,26(1):1-5. 被引量:29
  • 10徐成斌.他汀类药物治疗血脂异常的作用、地位和进展[J].中华内分泌代谢杂志,2000,16(6):385-388. 被引量:12

共引文献3096

同被引文献21

  • 1付文金,彭兰芬,叶长钦,蒋友明,程萍,李文忠.非高密度脂蛋白胆固醇与传统血脂指标的相关性分析[J].国际检验医学杂志,2007,28(8):705-707. 被引量:6
  • 2Shaw JE, Sieree RA, Zimmet PZ.Global estimates of the prevalence of diabetes for 2010 and 2030.Diabetes Resclin Pract,2010,87:4-14.
  • 3Yang W,Lu J,Weng J,et al.Prevalence of diabetes among men and women in China.N engl J Med, 2010,362 : 1090-101.
  • 4Shlipak MG,Katz R,Samak MJ,et al. Cystain C and prognosis for car- diovascular and kidney outcomes in elderly persons without chronic kidney disease.Ann Intern Med, 2006,145:237-246.
  • 5Parring HH,Persson F,Lewis JB,et al. Aliskiren combined with losar- tan in type 2 diabetes and nephropathy.N Engl J Med,2008,358: 2433-2446.
  • 6National Kidney Foundation.KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.Am J Kidney Dis. 2007.50: S 1-S 179.
  • 7Gaede P, Lund-Andersen H, Parring HH, et al.Effect of a multifacro- rial intervention on mortality in type 2 diabetes. Nengl J Med, 2008,358:580-591.
  • 8黄颂敏.重视糖尿病慢性肾疾病的早期筛查[J].肾脏病与透析肾移植杂志,2007,16(6):540-541. 被引量:10
  • 9雷静月.血尿酸与非高密度脂蛋白胆固醇关系的分析[J].浙江临床医学,2008,10(7):987-987. 被引量:2
  • 10金波,刘志红,葛永纯,谢红浪,王少凡,伏幼娟,黎磊石.肾活检患者中糖尿病肾病流行病学特点的变迁[J].肾脏病与透析肾移植杂志,2009,18(2):133-139. 被引量:45

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部